HLA-G and IL-10 expression in human cancer—different stories with the same message
- 31 October 2003
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 13 (5) , 337-342
- https://doi.org/10.1016/s1044-579x(03)00024-5
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Natural selection of tumor variants in the generation of “tumor escape” phenotypesNature Immunology, 2002
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- DNA methylation in cancer: too much, but also too littleOncogene, 2002
- HLA‐G and its KIR ligands in cancer – another enigma yet to be solved?The Journal of Pathology, 2002
- Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 ProductionThe American Journal of Pathology, 2001
- Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-? immunotherapyCancer, 2001
- HLA‐G has a concentration‐dependent effect on the generation of an allo‐CTL responseImmunology, 2000
- Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanomaThe Lancet, 2000
- NK cell recognition of non-classical HLA class I moleculesSeminars in Immunology, 2000